 |  |  |
| | |
 |  |
Home |
| | |||||
| |||||||
E-News Sign-up |
call toll-free in North America 1.888.591.5577 outside North America call +1.604.456.6010| Investors | |
 Investors | |
 | Stock Information |
| Regulatory Filings |
| Shareholder Update |
| CEO Message |
Stock Information
|
Response Biomedical is a publicly traded company, listed on the TSX Exchange under the trading symbol "RBM" and quoted on the OTC Bulletin Board under the symbol "RPBIF".
OTCBB Market Maker,
Public Securities Inc.,
Tel: 509.892.5590; 1.800.888.2325
Statements contained on this website relating to future results, events and expectations are forward-looking statements within the meaning of Section 21E of the United States Securities Exchange Act of 1934. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievement of the Company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such statements. Such factors include, among others, those described in the Company's annual report on Form 40-F.
Subscribe to RBM press releases, sent directly to your e-mail address on the day of the release.
Analyst Coverage
Response Biomedical is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Response Biomedical's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Response Biomedical or its management. Response Biomedical does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.